Literature DB >> 17389328

(How) can we prevent type 2 diabetes?

Thomas A Buchanan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17389328     DOI： 10.2337/db07-0140

Source DB:  PubMed          Journal:  Diabetes        ISSN： 0012-1797            Impact factor:   9.461


× No keyword cloud information.
  18 in total

1.  Approach to the patient with gestational diabetes after delivery.

Authors:  Thomas A Buchanan; Kathleen A Page
Journal:  J Clin Endocrinol Metab       Date:  2011-12       Impact factor: 5.958

2.  [Screening and prevention of diabetes].

Authors:  P E H Schwarz
Journal:  Internist (Berl)       Date:  2015-10       Impact factor: 0.743

3.  Healthy Living Partnerships to Prevent Diabetes (HELP PD): design and methods.

Authors:  Jeffrey A Katula; Mara Z Vitolins; Erica L Rosenberger; Caroline Blackwell; Mark A Espeland; Michael S Lawlor; W Jack Rejeski; David C Goff
Journal:  Contemp Clin Trials       Date:  2009-09-13       Impact factor: 2.226

4.  Diabetes Incidence and Glucose Tolerance after Termination of Pioglitazone Therapy: Results from ACT NOW.

Authors:  Devjit Tripathy; Dawn C Schwenke; MaryAnn Banerji; George A Bray; Thomas A Buchanan; Stephen C Clement; Robert R Henry; Abbas E Kitabchi; Sunder Mudaliar; Robert E Ratner; Frankie B Stentz; Nicolas Musi; Peter D Reaven; Ralph A DeFronzo
Journal:  J Clin Endocrinol Metab       Date:  2016-03-16       Impact factor: 5.958

Review 5.  The future of thiazolidinedione therapy in the management of type 2 diabetes mellitus.

Authors:  Hanford Yau; Kathya Rivera; Romina Lomonaco; Kenneth Cusi
Journal:  Curr Diab Rep       Date:  2013-06       Impact factor: 4.810

6.  The resist diabetes trial: Rationale, design, and methods of a hybrid efficacy/effectiveness intervention trial for resistance training maintenance to improve glucose homeostasis in older prediabetic adults.

Authors:  Elaina L Marinik; Sarah Kelleher; Jyoti Savla; Richard A Winett; Brenda M Davy
Journal:  Contemp Clin Trials       Date:  2013-11-16       Impact factor: 2.226

7.  Impact of Gastric Banding Versus Metformin on β-Cell Function in Adults With Impaired Glucose Tolerance or Mild Type 2 Diabetes.

Authors:  Anny H Xiang; Enrique Trigo; Mayra Martinez; Namir Katkhouda; Elizabeth Beale; Xinhui Wang; Jun Wu; Ting Chow; Cortney Montgomery; Krishna S Nayak; Fadi Hendee; Thomas A Buchanan
Journal:  Diabetes Care       Date:  2018-10-03       Impact factor: 19.112

8.  Counterpoint: postprandial glucose levels are not a clinically important treatment target.

Authors:  Mayer B Davidson
Journal:  Diabetes Care       Date:  2010-08       Impact factor: 19.112

Review 9.  Lessons learned from studying families genetically predisposed to type 2 diabetes mellitus.

Authors:  Kenneth Cusi
Journal:  Curr Diab Rep       Date:  2009-06       Impact factor: 4.810

Review 10.  Interventions to preserve beta-cell function in the management and prevention of type 2 diabetes.

Authors:  Kathleen A Page; Tamar Reisman
Journal:  Curr Diab Rep       Date:  2013-04       Impact factor: 4.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.